TY - JOUR
T1 - Genetics of GH Deficiency
T2 - Insights From a Cohort of 203 Patients
AU - Ribeiro, Ana Cláudia
AU - Coutinho, Eduarda
AU - Syed, Najeeb
AU - Bastos, Margarida
AU - Bacelar, Conceição
AU - Costa, Carla
AU - Freitas, Paula
AU - Gomes, Leonor
AU - Agapito, Ana
AU - Fonseca, Fernando
AU - Amaral, Daniela
AU - Carvalho, Davide
AU - Sampaio, Maria Lurdes
AU - Pereira, Bernardo Dias
AU - Antunes, Ana Maria
AU - Leite, Valeriano
AU - Castro, João Jácome
AU - Barros, Luísa
AU - Pina, Rosa
AU - Martins, Sofia Almeida
AU - Martinho, Mariana
AU - Martins, Diana
AU - Luiz, Henrique Vara
AU - Mirante, Alice
AU - Lopes, Lurdes
AU - Limbert, Catarina
AU - Pereira, Carla
AU - Gomes, Maria Miguel
AU - Cardoso, Helena
AU - Dinis, Isabel
AU - Paiva, Sandra
AU - Gonçalves, Catarina Inês
AU - Saraiva, Luís R.
AU - Lemos, Manuel Carlos
N1 - Publisher Copyright:
© The Author(s) 2025. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved.
PY - 2026/2/1
Y1 - 2026/2/1
N2 - Context: GH deficiency is a rare disorder characterized by severe short stature, which can result from genetic mutations affecting hypothalamic-pituitary development and function.
Objective: To determine the genetic basis of GH deficiency in a Portuguese cohort.
Design, Setting, Patients: Multicenter cohort of 203 GH-deficient patients (78 with isolated GH deficiency and 125 with combined pituitary hormone deficiency) were analyzed.Intervention Screening of a panel of 184 GH deficiency-related genes using Sanger sequencing and whole exome sequencing.
Main Outcome Measure: Rare sequence variants (population maximum allele frequency <0.01).
Results: A genetic cause was identified in 23.2% of patients (9.0% in isolated GH deficiency and 32.0% in combined pituitary hormone deficiency). Mutations were found in the PROP1 (14.8% of patients), GLI2 (2.0%), KMT2D (1.0%), PROK2 (1.0%), PROKR2 (1.0%), CDON (0.5%), COL1A2 (0.5%), COL2A1 (0.5%), GHRHR (0.5%), PTPN11 (0.5%), and SOX3 (0.5%) genes. One patient (0.5%) had a digenic mutation in the BMP4 and NF1 genes. Variants of uncertain significance were identified in 87.8% of patients.
Conclusion: This study revealed several novel and recurrent mutations that expand the genetic spectrum of GH deficiency and underscore the genetic heterogeneity of this disorder. A significant proportion of patients remained genetically undiagnosed, suggesting the involvement of additional unknown genetic, epigenetic, or environmental factors. These findings contribute to the understanding of the genetic architecture of GH deficiency and highlight the need for further investigations to elucidate underlying mechanisms and identify additional causative factors.
AB - Context: GH deficiency is a rare disorder characterized by severe short stature, which can result from genetic mutations affecting hypothalamic-pituitary development and function.
Objective: To determine the genetic basis of GH deficiency in a Portuguese cohort.
Design, Setting, Patients: Multicenter cohort of 203 GH-deficient patients (78 with isolated GH deficiency and 125 with combined pituitary hormone deficiency) were analyzed.Intervention Screening of a panel of 184 GH deficiency-related genes using Sanger sequencing and whole exome sequencing.
Main Outcome Measure: Rare sequence variants (population maximum allele frequency <0.01).
Results: A genetic cause was identified in 23.2% of patients (9.0% in isolated GH deficiency and 32.0% in combined pituitary hormone deficiency). Mutations were found in the PROP1 (14.8% of patients), GLI2 (2.0%), KMT2D (1.0%), PROK2 (1.0%), PROKR2 (1.0%), CDON (0.5%), COL1A2 (0.5%), COL2A1 (0.5%), GHRHR (0.5%), PTPN11 (0.5%), and SOX3 (0.5%) genes. One patient (0.5%) had a digenic mutation in the BMP4 and NF1 genes. Variants of uncertain significance were identified in 87.8% of patients.
Conclusion: This study revealed several novel and recurrent mutations that expand the genetic spectrum of GH deficiency and underscore the genetic heterogeneity of this disorder. A significant proportion of patients remained genetically undiagnosed, suggesting the involvement of additional unknown genetic, epigenetic, or environmental factors. These findings contribute to the understanding of the genetic architecture of GH deficiency and highlight the need for further investigations to elucidate underlying mechanisms and identify additional causative factors.
KW - Combined pituitary hormone deficiency
KW - Cphd
KW - GH deficiency
KW - Genetics
KW - Growth hormone deficiency
KW - Mutation
UR - https://www.scopus.com/pages/publications/105028029731
U2 - 10.1210/clinem/dgaf377
DO - 10.1210/clinem/dgaf377
M3 - Article
C2 - 40554621
AN - SCOPUS:105028029731
SN - 0021-972X
VL - 111
SP - e522-e534
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 2
ER -